-
1
-
-
34447543352
-
Art exhibition brings patient's stories to life
-
E. Cannell Art exhibition brings patient's stories to life. The Lancet Oncology 8 2 2007 109 110
-
(2007)
The Lancet Oncology
, vol.8
, Issue.2
, pp. 109-110
-
-
Cannell, E.1
-
2
-
-
33645745130
-
Skip metastases in osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group
-
L. Kager A. Zoubek U. Kastner Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. Journal of Clinical Oncology 24 10 2006 1535 1541
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.10
, pp. 1535-1541
-
-
Kager, L.1
Zoubek, A.2
Kastner, U.3
-
3
-
-
33646889372
-
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials
-
M. Eselgrim H. Grunert T. Kühne Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Pediatric Blood & Cancer 47 1 2006 42 50
-
(2006)
Pediatric Blood & Cancer
, vol.47
, Issue.1
, pp. 42-50
-
-
Eselgrim, M.1
Grunert, H.2
Kühne, T.3
-
4
-
-
33846981552
-
Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup
-
I. J. Lewis M. A. Nooij J. Whelan Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. Journal of the National Cancer Institute 99 2 2007 112 128
-
(2007)
Journal of the National Cancer Institute
, vol.99
, Issue.2
, pp. 112-128
-
-
Lewis, I.J.1
Nooij, M.A.2
Whelan, J.3
-
5
-
-
57349144538
-
Cooperative Osteosarcoma Study Group trial COSS-96 of intensive, risk-stratified chemotherapy for osteosarcoma
-
S. S. Bielack G. Delling R. Kotz Cooperative Osteosarcoma Study Group trial COSS-96 of intensive, risk-stratified chemotherapy for osteosarcoma. Sarcoma 9 1-2 2005 51
-
(2005)
Sarcoma
, vol.9
, Issue.12
, pp. 51
-
-
Bielack, S.S.1
Delling, G.2
Kotz, R.3
-
6
-
-
28844499178
-
Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: Discussion on the role of adjuvant therapies
-
cws.study@olgahospital.s.shuttle.de
-
I. B. Brecht cws.study@olgahospital.s.shuttle.de A. Ferrari C. Int-Veen Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies. Pediatric Blood & Cancer 46 1 2006 11 17
-
(2006)
Pediatric Blood & Cancer
, vol.46
, Issue.1
, pp. 11-17
-
-
Brecht, I.B.1
Ferrari, A.2
Int-Veen, C.3
-
7
-
-
33846959447
-
Safeguarding clinical trials
-
Safeguarding clinical trials. Nature Medicine 13 2007 2 107
-
(2007)
Nature Medicine
, vol.13
, Issue.2
, pp. 107
-
-
-
8
-
-
33846967435
-
Tied up in red tape, European trials shut down
-
B. Keim Tied up in red tape, European trials shut down. Nature Medicine 13 2 2007 110
-
(2007)
Nature Medicine
, vol.13
, Issue.2
, pp. 110
-
-
Keim, B.1
-
9
-
-
0035464534
-
Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft-tissue tumors. 3rd Interdisciplinary Consensus Conference "pET in Oncology": Results of the Bone and Soft-Tissue Study Group
-
franziu@uni-muenster.de
-
C. Franzius franziu@uni-muenster.de M. Schulte A. Hillmann Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft-tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft-Tissue Study Group. Der Chirurg 72 9 2001 1071 1077
-
(2001)
Der Chirurg
, vol.72
, Issue.9
, pp. 1071-1077
-
-
Franzius, C.1
Schulte, M.2
Hillmann, A.3
-
10
-
-
33947589938
-
Clinical trials directive slows registration of paediatric studies
-
E. Cannell Clinical trials directive slows registration of paediatric studies. The Lancet Oncology 8 1 2007 10
-
(2007)
The Lancet Oncology
, vol.8
, Issue.1
, pp. 10
-
-
Cannell, E.1
-
11
-
-
84878766680
-
-
http://www.siop.nl/content.asp?ID=345
-
-
-
|